insights_auto
Why is EDIT down 3.39%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$1.71
arrow_downward
-3.39%(-0.060) 1D
$1.75
arrow_upward
+2.13% (+0.036)bedtimeAfter hours
Closed: Nov 19, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$1.80
High
$1.83
Low
$1.70
Mkt. cap
263.92M
Avg. vol.
2.38M
Volume
1.93M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$1.80
High
$1.83
Low
$1.70
Mkt. cap
263.92M
Avg. vol.
2.38M
Volume
1.93M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
ChartMill
·
59 minutes ago
S&P 500 After-Hours Movers: Nov. 19, 2026
Traders Union
·
1 hour ago
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com